Suppr超能文献

利用免疫组织化学和放射免疫分析法对大鼠同种异体骨移植的研究。

Studies of allotransplantation of bone using immunohistochemistry and radioimmunoassay in rats.

作者信息

Shigetomi M, Kawai S, Fukumoto T

机构信息

Department of Orthopaedic Surgery, Yamaguchi University School of Medicine, Japan.

出版信息

Clin Orthop Relat Res. 1993 Jul(292):345-51.

PMID:8519130
Abstract

Immunohistochemistry and radioimmunoassay were used to study the rejection mechanism of allografted bone tissue in rats through changes in major histocompatibility complex (MHC) antigen expression by osteocytes in the allograft and in alloantibody levels in the serum of the host rats. Some osteocytes in normal rat bone tissue expressed MHC Class I antigen, and the degree of expression varied among the osteocytes. The expression of MHC Class I antigens on osteocytes of allografted bone tissue increased with time after allograft transplantation. When DA strain bone tissue was allografted to F344 strain host tissue, a marked decrease in the number of osteocytes was observed, and almost all of the remaining osteocytes strongly expressed MHC Class I antigens in the allografted bone tissue three weeks after transplantation. F344 strain rat recipients with DA strain rat bone grafts showed high titers of anti-Class I alloantibody. These titers increased two weeks after transplantation. Major histocompatibility complex Class I antigens on osteocytes may play an important role in allograft rejection, as has been observed in other transplanted organs in the rat.

摘要

采用免疫组织化学和放射免疫分析方法,通过观察同种异体移植骨组织中骨细胞主要组织相容性复合体(MHC)抗原表达的变化以及宿主大鼠血清中同种异体抗体水平的变化,研究大鼠同种异体移植骨组织的排斥机制。正常大鼠骨组织中的一些骨细胞表达MHCⅠ类抗原,且不同骨细胞的表达程度存在差异。同种异体移植骨组织骨细胞上MHCⅠ类抗原的表达在移植后随时间增加。当将DA品系骨组织移植到F344品系宿主组织时,观察到骨细胞数量明显减少,且在移植三周后,几乎所有剩余的骨细胞均在同种异体移植骨组织中强烈表达MHCⅠ类抗原。接受DA品系大鼠骨移植的F344品系大鼠受体显示出高滴度的抗Ⅰ类同种异体抗体。这些滴度在移植两周后升高。骨细胞上的主要组织相容性复合体Ⅰ类抗原可能在同种异体移植排斥中起重要作用,正如在大鼠的其他移植器官中所观察到的那样。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验